Natalya Barresi
Family · Venice, FLNPI 1689063935
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,494 of the $3,939 with a category attached, or 88.7%. It is spread thinly across 34 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 168 payments — averaging $23.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$518
- AstraZeneca$289
- Pfizer$269
- Daiichi Sankyo Inc.$264
- Eisai Inc.$257
- E.r. Squibb & Sons, L.L.C.$250
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,49489%
- Education$44511%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 17 | $518 |
| AstraZeneca(2 entities) | 10 | $289 |
| Pfizer | 14 | $269 |
| Daiichi Sankyo Inc. | 16 | $264 |
| Eisai Inc. | 13 | $257 |
| E.r. Squibb & Sons, L.L.C. | 13 | $250 |
| Amgen | 8 | $245 |
| Puma Biotechnology, Inc. | 8 | $231 |
| Johnson & Johnson | 8 | $212 |
| Merck | 9 | $166 |
| Lilly USA, LLC | 4 | $146 |
| Novartis | 6 | $134 |
| Genmab U.S., Inc. | 5 | $124 |
| Bayer | 5 | $96 |
| GSK | 4 | $74 |
| Sanofi-aventis U.S. LLC | 1 | $70 |
| AbbVie | 2 | $52 |
| Incyte Corporation | 2 | $52 |
| Bristol Myers Squibb | 2 | $46 |
| Myovant Sciences Inc. | 2 | $45 |
| Pharmaessentia USA Corporation | 2 | $41 |
| Janssen Scientific Affairs, LLC | 1 | $41 |
| Exelixis Inc. | 2 | $40 |
| Syndax Pharmaceuticals, Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Jazz Pharmaceuticals Inc. | 1 | $26 |
| EMD Serono, Inc. | 1 | $24 |
| ADC Therapeutics America, Inc. | 1 | $23 |
| Clovis Oncology, Inc. | 2 | $21 |
| Sanofi | 1 | $21 |
| Sobi, Inc | 1 | $21 |
| AVEO Pharmaceuticals, Inc. | 1 | $21 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TUKYSA$139
How this compares
$3,939 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Other family in Venice
- Lindsey WatfordVenice$43K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.